BLC Statistics
Total Valuation
Bastide Le Confort Médical has a market cap or net worth of EUR 154.19 million. The enterprise value is 540.18 million.
Market Cap | 154.19M |
Enterprise Value | 540.18M |
Important Dates
The next estimated earnings date is Wednesday, March 19, 2025.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Bastide Le Confort Médical has 7.31 million shares outstanding. The number of shares has increased by 0.04% in one year.
Current Share Class | n/a |
Shares Outstanding | 7.31M |
Shares Change (YoY) | +0.04% |
Shares Change (QoQ) | +12.88% |
Owned by Insiders (%) | 1.59% |
Owned by Institutions (%) | 16.41% |
Float | 3.29M |
Valuation Ratios
The trailing PE ratio is 22.62 and the forward PE ratio is 6.98.
PE Ratio | 22.62 |
Forward PE | 6.98 |
PS Ratio | 0.30 |
PB Ratio | 1.96 |
P/TBV Ratio | n/a |
P/FCF Ratio | 4.13 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.02, with an EV/FCF ratio of 14.48.
EV / Earnings | -600.20 |
EV / Sales | 1.02 |
EV / EBITDA | 5.02 |
EV / EBIT | 12.22 |
EV / FCF | 14.48 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 5.06.
Current Ratio | 0.97 |
Quick Ratio | 0.68 |
Debt / Equity | 5.06 |
Debt / EBITDA | 3.80 |
Debt / FCF | 10.96 |
Interest Coverage | 1.62 |
Financial Efficiency
Return on equity (ROE) is 11.24% and return on invested capital (ROIC) is 5.50%.
Return on Equity (ROE) | 11.24% |
Return on Assets (ROA) | 4.24% |
Return on Capital (ROIC) | 5.50% |
Revenue Per Employee | 145,737 |
Profits Per Employee | -248 |
Employee Count | 3,635 |
Asset Turnover | 0.81 |
Inventory Turnover | 3.82 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.45% in the last 52 weeks. The beta is 0.85, so Bastide Le Confort Médical's price volatility has been lower than the market average.
Beta (5Y) | 0.85 |
52-Week Price Change | -15.45% |
50-Day Moving Average | 19.42 |
200-Day Moving Average | 19.45 |
Relative Strength Index (RSI) | 66.54 |
Average Volume (20 Days) | 3,992 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bastide Le Confort Médical had revenue of EUR 529.76 million and -900,000 in losses. Loss per share was -0.11.
Revenue | 529.76M |
Gross Profit | 354.44M |
Operating Income | 44.22M |
Pretax Income | 16.50M |
Net Income | -900,000 |
EBITDA | 86.82M |
EBIT | 44.22M |
Loss Per Share | -0.11 |
Balance Sheet
The company has 23.62 million in cash and 408.65 million in debt, giving a net cash position of -385.03 million or -52.69 per share.
Cash & Cash Equivalents | 23.62M |
Total Debt | 408.65M |
Net Cash | -385.03M |
Net Cash Per Share | -52.69 |
Equity (Book Value) | 80.73M |
Book Value Per Share | 10.77 |
Working Capital | -7.28M |
Cash Flow
In the last 12 months, operating cash flow was 92.69 million and capital expenditures -55.40 million, giving a free cash flow of 37.29 million.
Operating Cash Flow | 92.69M |
Capital Expenditures | -55.40M |
Free Cash Flow | 37.29M |
FCF Per Share | 5.10 |
Margins
Gross margin is 66.91%, with operating and profit margins of 8.35% and -0.17%.
Gross Margin | 66.91% |
Operating Margin | 8.35% |
Pretax Margin | 3.12% |
Profit Margin | -0.17% |
EBITDA Margin | 16.39% |
EBIT Margin | 8.35% |
FCF Margin | 7.04% |
Dividends & Yields
Bastide Le Confort Médical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.04% |
Shareholder Yield | -0.04% |
Earnings Yield | -0.52% |
FCF Yield | 24.19% |
Stock Splits
The last stock split was on December 19, 2007. It was a forward split with a ratio of 3.00003.
Last Split Date | Dec 19, 2007 |
Split Type | Forward |
Split Ratio | 3.00003 |
Scores
Bastide Le Confort Médical has an Altman Z-Score of 1.35. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.35 |
Piotroski F-Score | n/a |